Alport Connect 2025 Meeting
19-20 July, 2025
Chicago, IL
Âé¶¹ÆÆ½â°æ is sponsoring and will attend Alport Connect 2025 organized by the American Alport Syndrome Foundation (ASF), the Alport syndrome patient-led non-profit organization in the US.
Âé¶¹ÆÆ½â°æ will meet patients and their families to present its ongoing Phase 2 “ALPESTRIA-1” clinical study with Vonafexor in Alport syndrome patients.